ReP USP - Resultado da busca

Artigo de periodico
Hypercholesterolemia and inflammation: cooperative cardiovascular risk factors (2025)
Gallo, Antonio; Goff, Wilfried Le; Santos Filho, Raul Dias dos ; Fichtner, Isabella; Carugo, Stefano; Corsini, Alberto; Sirtori, Cesare; Ruscica, Massimiliano
Source: European journal of clinical investigation. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, COLESTEROL, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALLO, Antonio et al. Hypercholesterolemia and inflammation: cooperative cardiovascular risk factors. European journal of clinical investigation, v. 55, n. 1, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/82750. Acesso em: 30 abr. 2026.
APA
Gallo, A., Goff, W. L., Santos Filho, R. D. dos, Fichtner, I., Carugo, S., Corsini, A., et al. (2025). Hypercholesterolemia and inflammation: cooperative cardiovascular risk factors. European journal of clinical investigation, 55( 1). doi:10.1111/eci.14326
NLM
Gallo A, Goff WL, Santos Filho RD dos, Fichtner I, Carugo S, Corsini A, Sirtori C, Ruscica M. Hypercholesterolemia and inflammation: cooperative cardiovascular risk factors [Internet]. European journal of clinical investigation. 2025 ; 55( 1):[citado 2026 abr. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82750
Vancouver
Gallo A, Goff WL, Santos Filho RD dos, Fichtner I, Carugo S, Corsini A, Sirtori C, Ruscica M. Hypercholesterolemia and inflammation: cooperative cardiovascular risk factors [Internet]. European journal of clinical investigation. 2025 ; 55( 1):[citado 2026 abr. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82750
Artigo de periodico
Fixed Combination for the Treatment of Dyslipidaemia (2023)
Ferri, Nicola ; Ruscica, Massimiliano; Santos Filho, Raul Dias dos ; Corsini, Alberto
Source: Current atherosclerosis reports. Unidade: FM
Subjects: ARTERIOSCLEROSE, DISLIPIDEMIAS, LIPÍDEOS E AGENTES ANTILIPÊMICOS, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRI, Nicola et al. Fixed Combination for the Treatment of Dyslipidaemia. Current atherosclerosis reports, v. 25, n. 10, p. 691-699, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57363. Acesso em: 30 abr. 2026.
APA
Ferri, N., Ruscica, M., Santos Filho, R. D. dos, & Corsini, A. (2023). Fixed Combination for the Treatment of Dyslipidaemia. Current atherosclerosis reports, 25( 10), 691-699. doi:10.1007/s11883-023-01142-x
NLM
Ferri N, Ruscica M, Santos Filho RD dos, Corsini A. Fixed Combination for the Treatment of Dyslipidaemia [Internet]. Current atherosclerosis reports. 2023 ; 25( 10): 691-699.[citado 2026 abr. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57363
Vancouver
Ferri N, Ruscica M, Santos Filho RD dos, Corsini A. Fixed Combination for the Treatment of Dyslipidaemia [Internet]. Current atherosclerosis reports. 2023 ; 25( 10): 691-699.[citado 2026 abr. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57363
Artigo de periodico
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation (2019)
Fruchart, Jean-Charles; Santos Filho, Raul Dias dos; Aguilar-salinas, Carlos; Aikawa, Masanori; Rasadi, Khalid Al; Amarenco, Pierre; Barter, Philip J; Ceska, Richard; Corsini, Alberto; Despres, Jean-Pierre
Source: Cardiovascular diabetology. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, ARTERIOSCLEROSE, DISLIPIDEMIAS, LIPÍDEOS, LIPOPROTEÍNAS HDL, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, PEROXISSOMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRUCHART, Jean-Charles et al. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. Cardiovascular diabetology, v. 18, 2019Tradução . . Disponível em: https://doi.org/10.1186/s12933-019-0864-7. Acesso em: 30 abr. 2026.
APA
Fruchart, J. -C., Santos Filho, R. D. dos, Aguilar-salinas, C., Aikawa, M., Rasadi, K. A., Amarenco, P., et al. (2019). The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. Cardiovascular diabetology, 18. doi:10.1186/s12933-019-0864-7
NLM
Fruchart J-C, Santos Filho RD dos, Aguilar-salinas C, Aikawa M, Rasadi KA, Amarenco P, Barter PJ, Ceska R, Corsini A, Despres J-P. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation [Internet]. Cardiovascular diabetology. 2019 ; 18[citado 2026 abr. 30 ] Available from: https://doi.org/10.1186/s12933-019-0864-7
Vancouver
Fruchart J-C, Santos Filho RD dos, Aguilar-salinas C, Aikawa M, Rasadi KA, Amarenco P, Barter PJ, Ceska R, Corsini A, Despres J-P. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation [Internet]. Cardiovascular diabetology. 2019 ; 18[citado 2026 abr. 30 ] Available from: https://doi.org/10.1186/s12933-019-0864-7
Artigo de periodico
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (2015)
Stroes, Erik S.; Thompson , Paul D.; Corsini, Alberto; Vladutiu, Georgirene D.; Raal, Frederick J.; Ray, Kausik K.; Roden, Michael; Stein, Evan; Tokgözoğlu, Lale; Nordestgaard, Børge G.; Bruckert, Eric; De Backer, Guy; Krauss, Ronald M.; Laufs, Ulrich; Santos, Raul D.; Hegele, Robert A.; Hovingh, G. Kees; Leiter, Lawrence A.; Mach, Francois; März, Winfried; Newman, Connie B.; Wiklund, Olov; Jacobson, Terry A.; Catapano, Alberico L.; Chapman, M. John; Ginsberg, Henry N.
Source: European heart journal. Unidade: FM
Subjects: SINAIS E SINTOMAS, COLESTEROL, MEDICAMENTO (ADMINISTRAÇÃO E DOSAGEM), FISIOPATOLOGIA, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STROES, Erik S. et al. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. European heart journal, v. 36, p. 1012-1022, 2015Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehv043. Acesso em: 30 abr. 2026.
APA
Stroes, E. S., Thompson , P. D., Corsini, A., Vladutiu, G. D., Raal, F. J., Ray, K. K., et al. (2015). Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. European heart journal, 36, 1012-1022. doi:10.1093/eurheartj/ehv043
NLM
Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, Roden M, Stein E, Tokgözoğlu L, Nordestgaard BG, Bruckert E, De Backer G, Krauss RM, Laufs U, Santos RD, Hegele RA, Hovingh GK, Leiter LA, Mach F, März W, Newman CB, Wiklund O, Jacobson TA, Catapano AL, Chapman MJ, Ginsberg HN. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management [Internet]. European heart journal. 2015 ; 36 1012-1022.[citado 2026 abr. 30 ] Available from: https://doi.org/10.1093/eurheartj/ehv043
Vancouver
Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, Roden M, Stein E, Tokgözoğlu L, Nordestgaard BG, Bruckert E, De Backer G, Krauss RM, Laufs U, Santos RD, Hegele RA, Hovingh GK, Leiter LA, Mach F, März W, Newman CB, Wiklund O, Jacobson TA, Catapano AL, Chapman MJ, Ginsberg HN. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management [Internet]. European heart journal. 2015 ; 36 1012-1022.[citado 2026 abr. 30 ] Available from: https://doi.org/10.1093/eurheartj/ehv043

USP Schools

ReP

Filtros

Authors

Subjects